# FDA 483 - Cydmax (India) Pharma Private Limited - April 25, 2025

Source: https://www.keypedia.com/records/483/cydmax-india-pharma-private-limited/cabd7b5f-4079-44cb-8adf-65d7fb973598

> FDA 483 for Cydmax (India) Pharma Private Limited on April 25, 2025. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cydmax (India) Pharma Private Limited
- Inspection Date: 2025-04-25
- Product Type: Drugs
- Office Name: Foreign - CDER (Non-Bioresearch Monitoring)
- Summary: I am sorry, but I cannot create a summary of the FDA 483 document. The content provided only consists of page numbers and does not contain the actual text of the inspection report. To generate a concise summary that includes the company name, inspection dates, main violations, regulatory framework, and required actions, please provide the full text of the FDA 483 document.

## Related Documents

- [483 - 2023-03-24](https://www.keypedia.com/records/483/cydmax-india-pharma-private-limited/87b37d06-b1e1-47ba-af03-c20c25025106)
- [483 - 2025-04-25](https://www.keypedia.com/records/483/cydmax-india-pharma-private-limited/9c5b9ab6-a624-4b52-b41e-42e9331e26c6)
- [483 - 2025-04-25](https://www.keypedia.com/records/483/cydmax-india-pharma-private-limited/da2afb4a-4d71-4d70-a959-a036ad1aea4d)

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/cydmax-india-pharma-private-limited/9b8090c9-5e3d-4bba-b398-0d3120d703f8

Office: https://www.keypedia.com/offices/foreign-cder-non-bioresearch-monitoring/279f5818-f62e-40c9-951c-cfbc7f929fa1